Determination of a clinically effective evobrutinib dose: Exposure-response analyses of a phase II relapsing multiple sclerosis study

Papasouliotis, O; Mitchell, D; Girard, P; Dangond, F; Dyroff, M

Papasouliotis, O (通讯作者)，Merck Inst Pharmacometr, Translat Med, EPFL Innovat Pk,Bldg 1, CH-1015 Lausanne, Switzerland.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022; 15 (12): 2888

Abstract

The pharmacometric analysis of the double-blind, randomized, phase II study (NCT02975349) investigating the safety and efficacy of evobrutinib, explor......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索